Beijing Sun-Novo Pharmaceutical Research Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 232.43 million compared to CNY 147.96 million a year ago. Revenue was CNY 232.43 million compared to CNY 147.96 million a year ago.

Net income was CNY 47.94 million compared to CNY 33.4 million a year ago. Basic earnings per share from continuing operations was CNY 0.4286 compared to CNY 0.3 a year ago. Diluted earnings per share from continuing operations was CNY 0.4286 compared to CNY 0.3 a year ago.